Jacobson Pharma (2633.HK) Earnings Analysis
Jacobson Pharma (2633.HK) next reports earnings on 2026-11-20. Trailing P/E 7.15.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2633.HK next report earnings?
| Next earnings date | 2026-11-20 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2633.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-23 | 0.08 HKD | n/a | n/a | n/a |
| 2025-11-18 | 0.0712 HKD | n/a | n/a | n/a |
| 2025-06-13 | 0.0809 HKD | n/a | n/a | n/a |
| 2024-11-21 | 0.03088 HKD | n/a | n/a | n/a |
2633.HK valuation and analyst view
| Trailing P/E | 7.15 |
|---|---|
| Trailing EPS | 0.15083 HKD |
| Price / book | 0.93 |
| Dividend yield | 14.58% |
| Market cap | 2.16B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jacobson Pharma (2633.HK)'s next earnings date?
Jacobson Pharma is next scheduled to report on 2026-11-20.
Did 2633.HK beat earnings last quarter?
Consensus estimate data was not available for 2633.HK's 2026-06-23 report.
What is 2633.HK's current P/E ratio and EPS?
2633.HK trades at a trailing P/E of 7.15 on trailing EPS of 0.15082554328639136 HKD.
What do analysts rate 2633.HK?
2633.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.